Drug information provided by: Merative, Micromedex®
Peginesatide injection is used to treat anemia in patients with chronic kidney disease (CKD) who are on dialysis.
This medicine was available only with your doctor's prescription.
Peginesatide was voluntarily withdrawn from the U.S. market on February 24, 2013 due to safety concerns for serious allergic reactions.
Portions of this document last updated: Feb. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
A generous benefactor has pledged $1 million and challenged us to raise an additional $250,000. Help us reach our goal!